3-氨基-5-溴噻吩-2-羧酰胺合成路线 (共 6 条)
反应条件
trifluoroacetic acid in dichloromethane
T=20°C; 1 h;
参考文献
ASTRAZENECA AB; ASTRAZENECA UK LIMITED
Patent: WO2004/63186 A1, 2004 ;
Location in patent: Page 37 ;
WO 2004/063186 A1
反应条件
1: With sodium hydroxide in methanol; water; N,N-dimethyl-formamide
T=70°C;
2: With hydrogenchloride; ammonium chloride; triethylamine in water; N,N-dimethyl-formamide
T=20°C; 0.0833333 h;
3: With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride in water; N,N-dimethyl-formamide
T=20°C; 120 h;
参考文献
Takeda Pharmaceutical Company Limited
Patent: EP2540728 A1, 2013 ;
Location in patent: Page/Page column 44 ;
反应条件
1: With ammonium chloride; triethylamine in N,N-dimethyl-formamide
0.166667 h;
2: With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride in N,N-dimethyl-formamide
96 h; Product distribution / selectivity;
参考文献
TAKEDA PHARMACEUTICAL COMPANY LIMITED; OGURO, Yuya; KURASAWA, Osamu
Patent: WO2010/101302 A1, 2010 ;
Location in patent: Page/Page column 131-132 ;
WO 2010/101302 A1
反应条件
1.1: pyridine / acetonitrile / 0 - 20 °C / Cooling with ice
2.1: diisopropylamine; n-butyllithium / hexane; tetrahydrofuran / 1 h / -78 °C
2.2: 1 h / -78 - 20 °C
3.1: potassium carbonate; methanol / water / 2 h / 20 °C
4.1: sodium hydroxide / N,N-dimethyl-formamide; water; methanol / 70 °C
4.2: 0.08 h / 20 °C
4.3: 120 h / 20 °C
View Scheme
参考文献
Takeda Pharmaceutical Company Limited
Patent: EP2540728 A1, 2013 ;
反应条件
1.1: potassium carbonate; methanol / water / 2 h / 20 °C
2.1: sodium hydroxide / N,N-dimethyl-formamide; water; methanol / 70 °C
2.2: 0.08 h / 20 °C
2.3: 120 h / 20 °C
View Scheme
参考文献
Takeda Pharmaceutical Company Limited
Patent: EP2540728 A1, 2013 ;
反应条件
1.1: diisopropylamine; n-butyllithium / hexane; tetrahydrofuran / 1 h / -78 °C
1.2: 1 h / -78 - 20 °C
2.1: potassium carbonate; methanol / water / 2 h / 20 °C
3.1: sodium hydroxide / N,N-dimethyl-formamide; water; methanol / 70 °C
3.2: 0.08 h / 20 °C
3.3: 120 h / 20 °C
View Scheme
参考文献
Takeda Pharmaceutical Company Limited
Patent: EP2540728 A1, 2013 ;